Crossmark

Cost-effectiveness of the combination of immunotherapy and chemotherapy for extensive-stage small-cell lung cancer: a systematic review

Published Online: 2023-06-26

Authors

Wang, Tao

Li, Yilin

Zheng, Xiaoqiang
License Information

Text and Data Mining valid from 2023-06-26

Version of Record valid from 2023-06-26
More Information

Article History

Received: 11 September 2022

Accepted: 20 June 2023

First Online: 26 June 2023

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current